Anticoccidial Drugs Market by Type (Antibiotic Anticoccidials, Chemical Derivative Anticoccidials, Ionophore Anticoccidials), Animal Type (Aquaculture, Livestock, Poultry) - Global Forecast 2024-2030

Anticoccidial Drugs Market by Type (Antibiotic Anticoccidials, Chemical Derivative Anticoccidials, Ionophore Anticoccidials), Animal Type (Aquaculture, Livestock, Poultry) - Global Forecast 2024-2030


The Anticoccidial Drugs Market size was estimated at USD 1.62 billion in 2023 and expected to reach USD 1.76 billion in 2024, at a CAGR 9.39% to reach USD 3.04 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anticoccidial Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anticoccidial Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anticoccidial Drugs Market, highlighting leading vendors and their innovative profiles. These include Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Fengchen Group Co., Ltd., Hipra Laboratories, S.A., Huvepharma EOOD, Impextraco NV, Intas Pharmaceuticals Ltd., Jurox Pty Limited, Kaken Pharmaceutical Co. Ltd., Kemin Industries Inc., Merck & Co., Inc., Novartis AG, Phibro Animal Health Corporation, Qilu Animal Health Products Co., Ltd., Salius Pharma Pvt. Ltd., TOKU-E, VH Group, Virbac Group, VIVAN Life Sciences Pvt. Limited, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Anticoccidial Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

Antibiotic Anticoccidials
  • Chemical Derivative Anticoccidials
  • Ionophore Anticoccidials
  • Animal Type

    Aquaculture
  • Livestock
  • Poultry
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Anticoccidial Drugs Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anticoccidial Drugs Market?
    3. What are the technology trends and regulatory frameworks in the Anticoccidial Drugs Market?
    4. What is the market share of the leading vendors in the Anticoccidial Drugs Market?
    5. Which modes and strategic moves are suitable for entering the Anticoccidial Drugs Market?


    Note: PDF & Excel + Online Access - 1 Year

  • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Anticoccidial Drugs Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Rising prevalence of coccidiosis in livestock
    5.1.1.2. Growing improvements in animal husbandry practices
    5.1.1.3. Increasing government investments in improving animal welfare
    5.1.2. Restraints
    5.1.2.1. Stringent government regulations for anticoccidial drugs
    5.1.3. Opportunities
    5.1.3.1. Development of advanced anticoccidial drugs
    5.1.3.2. Introduction of coccidiosis management initiatives by manufacturers
    5.1.4. Challenges
    5.1.4.1. Availability of alternative medicines and treatments
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Anticoccidial Drugs Market, by Type
    6.1. Introduction
    6.2. Antibiotic Anticoccidials
    6.3. Chemical Derivative Anticoccidials
    6.4. Ionophore Anticoccidials
    7. Anticoccidial Drugs Market, by Animal Type
    7.1. Introduction
    7.2. Aquaculture
    7.3. Livestock
    7.4. Poultry
    8. Americas Anticoccidial Drugs Market
    8.1. Introduction
    8.2. Argentina
    8.3. Brazil
    8.4. Canada
    8.5. Mexico
    8.6. United States
    9. Asia-Pacific Anticoccidial Drugs Market
    9.1. Introduction
    9.2. Australia
    9.3. China
    9.4. India
    9.5. Indonesia
    9.6. Japan
    9.7. Malaysia
    9.8. Philippines
    9.9. Singapore
    9.10. South Korea
    9.11. Taiwan
    9.12. Thailand
    9.13. Vietnam
    10. Europe, Middle East & Africa Anticoccidial Drugs Market
    10.1. Introduction
    10.2. Denmark
    10.3. Egypt
    10.4. Finland
    10.5. France
    10.6. Germany
    10.7. Israel
    10.8. Italy
    10.9. Netherlands
    10.10. Nigeria
    10.11. Norway
    10.12. Poland
    10.13. Qatar
    10.14. Russia
    10.15. Saudi Arabia
    10.16. South Africa
    10.17. Spain
    10.18. Sweden
    10.19. Switzerland
    10.20. Turkey
    10.21. United Arab Emirates
    10.22. United Kingdom
    11. Competitive Landscape
    11.1. FPNV Positioning Matrix
    11.2. Market Share Analysis, By Key Player
    11.3. Competitive Scenario Analysis, By Key Player
    12. Competitive Portfolio
    12.1. Key Company Profiles
    12.1.1. Bioproperties Pty Ltd.
    12.1.2. Boehringer Ingelheim International GmbH
    12.1.3. Ceva Sante Animale
    12.1.4. Cronus Pharma
    12.1.5. Elanco Animal Health Inc.
    12.1.6. Fengchen Group Co., Ltd.
    12.1.7. Hipra Laboratories, S.A.
    12.1.8. Huvepharma EOOD
    12.1.9. Impextraco NV
    12.1.10. Intas Pharmaceuticals Ltd.
    12.1.11. Jurox Pty Limited
    12.1.12. Kaken Pharmaceutical Co. Ltd.
    12.1.13. Kemin Industries Inc.
    12.1.14. Merck & Co., Inc.
    12.1.15. Novartis AG
    12.1.16. Phibro Animal Health Corporation
    12.1.17. Qilu Animal Health Products Co., Ltd.
    12.1.18. Salius Pharma Pvt. Ltd.
    12.1.19. TOKU-E
    12.1.20. VH Group
    12.1.21. Virbac Group
    12.1.22. VIVAN Life Sciences Pvt. Limited
    12.1.23. Zoetis Inc.
    12.2. Key Product Portfolio
    13. Appendix
    13.1. Discussion Guide
    13.2. License & Pricing
    FIGURE 1. ANTICOCCIDIAL DRUGS MARKET RESEARCH PROCESS
    FIGURE 2. ANTICOCCIDIAL DRUGS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ANTICOCCIDIAL DRUGS MARKET DYNAMICS
    FIGURE 7. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    FIGURE 8. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
    FIGURE 10. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 12. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 14. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 20. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings